STOCK TITAN

Verano to Hold Conference Call to Discuss Rescheduling of Fourth Quarter and Full Year 2021 Financial Results on Wednesday, April 6th at 6:00 p.m. ET / 5:00 p.m. CT

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

On April 6, 2022, Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced the rescheduling of its fourth quarter and full year 2021 financial results, initially set for April 7. The conference call will now take place on April 6 at 6:00 p.m. ET. Verano is a prominent multi-state cannabis operator in the U.S., providing access to regulated cannabis products through its brands like Verano™, Avexia™, and MÜV™. The company operates in 15 states with over 1,000,000 square feet of cultivation capacity.

Positive
  • Verano operates in 15 U.S. states, enhancing market presence.
  • The company has over 1,000,000 square feet of cultivation capacity, supporting product supply.
Negative
  • None.

CHICAGO, April 06, 2022 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that the Company will hold a conference call on Wednesday, April 6th at 6:00 p.m. ET / 5:00 p.m. CT, to discuss the decision to reschedule its fourth quarter and full year 2021 financial results, which had previously been scheduled for Thursday, April 7th at 8:30 a.m. ET / 7:30 a.m. CT.

Participants can access the conference call via the following:

About Verano

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano, Avexia, Encore, and MÜV. Verano’s portfolio encompasses 15 U.S. states, with active operations in 13, including 12 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf and MÜV, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at www.verano.com.

Contacts:

Investors
Verano
Julianna Paterra, CFA
Director, Investor Relations
julianna.paterra@verano.com

Media
Verano
Steve Mazeika
Director, Communications
steve.mazeika@verano.com
312-348-4430

Forward Looking Statements

This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements or information with respect to the Company’s position in the marketplace, and the Company’s operations. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without limitation, the risk factors discussed in the Company's filings on SEDAR at www.sedar.com. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

###


FAQ

When will Verano Holdings announce its 2021 financial results?

Verano Holdings will announce its 2021 financial results during a conference call on April 6, 2022, at 6:00 p.m. ET.

What is the stock symbol for Verano Holdings?

The stock symbol for Verano Holdings is VRNOF on the OTCQX.

How many states does Verano Holdings operate in?

Verano Holdings operates in 15 U.S. states.

What brands does Verano Holdings offer?

Verano Holdings offers brands such as Verano™, Avexia™, Encore™, and MÜV™.

VERANO HLDGS CORP

OTC:VRNOF

VRNOF Rankings

VRNOF Latest News

VRNOF Stock Data

454.84M
302.30M
14.26%
10.54%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago